Last reviewed · How we verify
AT-301A
At a glance
| Generic name | AT-301A |
|---|---|
| Also known as | Placebo |
| Sponsor | Atossa Therapeutics, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- AT-301 Nasal Spray in Healthy Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AT-301A CI brief — competitive landscape report
- AT-301A updates RSS · CI watch RSS
- Atossa Therapeutics, Inc. portfolio CI